IDiyas

For the Inventor, By the Inventor

Kanagawa, Japan

Toshihiro Imaeda

USPTO Granted Patents = 22 

 

Average Co-Inventor Count = 6.5

ph-index = 5

Forward Citations = 89(Granted Patents)


Location History:

  • Tsukuba, JP (2001 - 2005)
  • Osaka, JP (2013)
  • New York, NY (US) (2019)
  • Fujisawa, JP (2018 - 2022)
  • Kanagawa, JP (2014 - 2023)

Company Filing History:

goldMedal15 out of 1,177 
 
Takeda Pharmaceutical Company Limited
 patents
silverMedal3 out of 1,360 
 
Cornell University
 patents
bronzeMedal3 out of 8 
 
Tri-institutional Therapeutics Discovery Institute
 patents
4. 2 out of 1,858 
 
Takeda Chemical Industries, Inc.
 patents
5. 1 out of 712 
 
The Rockefeller University
 patents
6. 1 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 2001-2025

Loading Chart...
Loading Chart...
22 patents (USPTO):
1. 12473331 - Macrocyclic compounds as proteasome inhibitors (2025-11-18),
2. 12378256 - Heterocyclic compound (2025-08-05),
3. 11834515 - Macrocyclic compounds as proteasome inhibitors (2023-12-05),
4. 11732005 - Peptidomimetic proteasome inhibitors (2023-08-22),
5. 11414422 - Substituted pyrido[4,3-b]indoles and azepino[4,5-b]indoles as inhibitors of cGAS (2022-08-16),
6. 11279713 - Heterocyclic compound and use thereof (2022-03-22),
7. 11236099 - Heterocyclic compound (2022-02-01),
8. 11203613 - Peptidomimetic proteasome inhibitors (2021-12-21),
9. 10654874 - Heterocyclic compound and use thereof (2020-05-19),
10. 10214508 - Nitrogen-containing heterocyclic compound (2019-02-26),
11. 10131653 - Heterocyclic compound (2018-11-20),
12. 9884875 - Heterocyclic compound and use thereof (2018-02-06),
13. 9527807 - Sulfonamide derivative and use thereof (2016-12-27),
14. 9499568 - Heterocyclic compound and use thereof (2016-11-22),
15. 9371320 - Heterocyclic compound (2016-06-21),

Dear visitor, thank you for your interest in inventor Toshihiro Imaeda. Here is an article highlighting his dedication to innovation and the impact of his work:

Title: Toshihiro Imaeda: A Trailblazer in Innovation

Introduction:

Toshihiro Imaeda, a prolific inventor based in Kanagawa, Japan, is known for his relentless pursuit of excellence in the world of technology. With a remarkable portfolio of 20 patents, his work continues to inspire the next generation of inventors and researchers.

Latest Patents:

Imaeda's latest patents include groundbreaking inventions such as Macrocyclic Compounds as Proteasome Inhibitors and Peptidomimetic Proteasome Inhibitors. These compounds have diverse applications ranging from the treatment of bacterial, parasite, and fungal infections to cancer, autoimmune disorders, and neurodegenerative diseases.

Career Highlights:

Imaeda has made significant contributions to the field of biotechnology through his work at renowned companies like Takeda Pharmaceutical Company Limited and Takeda Chemical Industries, Inc. His innovative approach to drug discovery and development has paved the way for novel treatments in various therapeutic areas.

Collaborations:

Throughout his career, Imaeda has collaborated with esteemed coworkers such as Masakuni Kori and Shinji Nakamura. Together, they have pushed the boundaries of scientific research and brought forth groundbreaking solutions to complex medical challenges.

Conclusion:

In conclusion, Toshihiro Imaeda's passion for innovation and his commitment to excellence have left an indelible mark on the world of technology. His pioneering work serves as a beacon of inspiration for aspiring inventors and researchers worldwide, shaping the future of biotechnology and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…